Novo Nordisk’s semaglutide diabetes and weight loss drugs, Ozempic and Wegovy, are no longer officially in shortage in the US ...

Novo Nordisk’s weight loss drug Wegovy is linked to an increased risk of hair loss, a study suggests. Meanwhile, Dexcom ...

BofA analyst Allen Lutz notes that the Food and Drug Administration yesterday provided updated enforcement timelines for semaglutide and ...

In its Monday update, the FDA clarified that state-licensed compounding pharmacies and outsourcing facilities — which make ...

A study in people with obesity and diabetes again found CagriSema helps people lose weight, but not by enough to clearly ...

Novo Nordisk released the results from its late-stage trial of CagriSema on Monday. It showed that patients on the highest dose of the drug lost 15.7% of their weight.

But the newest study that has gone viral is an even more impressive outcome. Headlines are claiming that researchers have ...

Mass General Brigham researchers found that total weight loss did not increase for patients who took semaglutide before ...

Viatris Inc. (VTRS) recently reported a fourth quarter that fell short of Wall Street expectations, missing revenue and ...

Rybelsus (semaglutide) and Ozempic (semaglutide) are brand-name drugs. They’re both prescribed to help manage blood sugar levels in adults with type 2 diabetes. Continue reading to learn about ...

These trends reflect a dynamic market where consumers are looking to their drinks to deliver bold experiences, comforting familiarity, health-conscious options, and functional benefits.

Ozempic (semaglutide) is prescribed to treat type 2 diabetes mellitus. It works by stimulating insulin to manage blood sugar levels. It also slows down digestion and provides signals to the brain that ...